The nasal spray ... allergy. It should be seen as a rescue, but additional treatment may be needed in the ER," Gounder said. Gounder says the drug is meant to be available about eight weeks from ...

The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS Pharmaceuticals ...

U.S. health officials on Friday approved a nasal spray to treat severe ... She said, “we are over the moon” about the FDA’s approval of the spray, which Zacky will start carrying when ...

a director for the FDA’s Center for Drug Evaluation and Research. Neffy is a single-dose nasal spray approved by drugmaker ARS Pharmaceuticals Inc. that administers epinephrine, the only life ...

associate director of FDA’s Division of Pulmonology, Allergy and Critical Care, said in a statement. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of ...

A newly approved nasal spray for serious allergic ... to fear of injections,” Kelly Stone, FDA’s associate director of the Division of Pulmonology, Allergy and Critical Care, said in a statement.

According to ARS, the FDA regulators decided at the time that more data was needed to evaluate the safety of repeated doses of the nasal spray before it could be approved. "Neffy is epinephrine ...

The Food and Drug Administration approved Friday a nasal spray for serious ... injections," Kelly Stone, FDA's associate director of the Division of Pulmonology, Allergy and Critical Care, said ...

allergy, and critical care in the FDA’s Center for Drug Evaluation and Research, in a statement. “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of ...